reviewFrontiers in ImmunologyOct 14, 2020GOLD OA

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

Weill Cornell Medical College in Qatar

PubMed
Indexed incrossrefdoajpubmed

Abstract

A novel coronavirus, which has been designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and causes the highly infectious disease referred to as COVID-19. COVID-19 has now spread worldwide to become a global pandemic affecting over 24 million people as of August 26th, 2020 and claimed the life of more than 800,000 people worldwide. COVID-19 is asymptomatic for some individuals and for others it can cause symptoms ranging from flu-like to acute respiratory distress syndrome (ARDS), pneumonia and death. Although it is anticipated that an effective vaccine will be available to protect against COVID-19, at present the world is relying on…

Citation impact

560
total citations
FWCI
12.35
Percentile
100%
References
60
Citations per year

Authors

4

Topics & keywords

Keywords
  • Medicine
  • Pandemic
  • Coronavirus disease 2019 (COVID-19)
  • Intensive care medicine
  • Clinical trial
  • Pneumonia
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Vaccine efficacy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.